$CVM SEC Filings

Filed On	Filing
01 Oct 2026	Form 4: Talor Eyal, Chief Scientific Officer Received 1,165 shares as a grant or award ($2.4K)
01 Oct 2026	Form 4: Prichep Patricia B, Chief Financial Officer Received 2,082 shares as a grant or award ($4.29K)
01 Oct 2026	Form 4: Kersten Geert R, Director Received 2,621 shares as a grant or award ($5.4K)
03 Sep 2026	FORM S-8
26 Aug 2026	Form 4: Kersten Geert R, Director Bought 100,000 shares ($138K)
17 Aug 2026	Form 4: Watson Robert Eugene, Director Granted 110,000 Options ($1.1K)
17 Aug 2026	Form 4: Baillavoine Bruno Jean-marie, Director Granted 110,000 Options ($1.1K)
17 Aug 2026	Form 4: Cipriano John, Senior Vice President Granted 80,000 Options ($800)
17 Aug 2026	Form 4: Talor Eyal, Chief Scientific Officer Granted 250,000 Options ($2.5K)
17 Aug 2026	Form 4: Prichep Patricia B, Chief Financial Officer Granted 225,000 Options ($2.25K)
17 Aug 2026	Form 4: Kersten Geert R, Director Granted 300,000 Options ($3K)
17 Aug 2026	8-K: Submission of Matters to a Vote of Security Holders
14 Aug 2026	FORM 10-Q
02 Jul 2026	ARS
02 Jul 2026	Proxy statement: annual meeting on August 14, 2026 say-on-pay vote
01 Jul 2026	Form 4: Talor Eyal, Chief Scientific Officer Received 2,307 shares as a grant or award ($2.4K)
01 Jul 2026	Form 4: Prichep Patricia B, Chief Financial Officer Received 4,125 shares as a grant or award ($4.29K)
01 Jul 2026	Form 4: Kersten Geert R, Director Received 5,192 shares as a grant or award ($5.4K)
16 Jun 2026	8-K: Entry into a Material Definitive Agreement; Other Events
15 Jun 2026	FORM 424B5

Comments